Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bids Rumored For Stake In Wockhardt

Cipla And Dr Reddy’s Among Bids Rumored For Late November

Executive Summary

A clutch of domestic suitors and global private-equity funds are conducting due diligence with an eye to acquiring segments of debt-laden Indian firm Wockhardt and bids are expected in late November, according to a new report.

You may also be interested in...



A Decade’s Deals In Indian Pharma Point To 2020 Trends

A look at corporate acquisitions and private equity deals in the Indian pharmaceutical industry over 2010-2019 reveals some trends, lessons and targets for possible activity in 2020.

Cipla Rumored Frontrunner For Wockhardt Deal

Cipla is reportedly leading the pack to acquire business divisions of debt-laden Wockhardt in a transaction that could be worth hundreds of millions of dollars and would boost the Mumbai-based company’s domestic presence.

Buyout Firms Eye Wockhardt’s Domestic Formulations Unit

Private-equity firms are reportedly in talks to acquire a controlling stake in the domestic formulations business of India’s Wockhardt, which is seeking funds to pay down significant debts.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

GB149375

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel